Astrotech (US:ASTC)2025-02-14 13:47Financial Performance - Fiscal year 2025 Q2 revenue was $295 thousand, primarily from activities supporting the U.S. Department of Homeland Security[4] - The company reported a net loss of $4,009 thousand for the three months ended December 31, 2024, compared to a net loss of $2,641 thousand for the same period in 2023[9] - Astrotech's gross profit for Q2 2025 was $164 thousand, compared to $532 thousand in Q2 2024[9] - The company’s operating expenses for Q2 2025 were $4,476 thousand, an increase from $3,600 thousand in Q2 2024[9] - Research and development expenses increased to $2,437 thousand in Q2 2025 from $1,578 thousand in Q2 2024[9] - Astrotech's accumulated deficit reached $244,307 thousand as of December 31, 2024[10] Assets and Investments - Astrotech's cash and cash equivalents and liquid investments totaled $24.7 million, supporting research and development and potential acquisitions[4] - Astrotech's consolidated balance sheet shows total assets of $31,001 thousand as of December 31, 2024[10] Product Development - The company introduced the TRACER NTD narcotics trace detector, capable of accurately identifying fentanyl and other drugs[3] - The company received a purchase order for TRACER 1000 explosive trace detectors from Intuitive Research and Technology Corporation[4]